Nasdaq: SLABSilicon Labs

    Silicon Labs Q3 2026 Results: Net Income $8.85 Million on Revenue of $251 Million

    • US stocks
    • Earnings
    • Information Technology
    An etched copper circuit board with its traces exposed
    Tinux, via Wikimedia Commons (CC0). Illustrative image.

    Silicon Labs (Nasdaq: SLAB) reported GAAP revenue of $250.9 million and GAAP net income of $8.9 million for the third quarter of 2026, which ended 3 Oct 2026; it said on 10 Nov 2026. GAAP diluted EPS was $0.26, and adjusted EPS, a company-defined measure that excludes stock compensation, amortization of acquired intangible assets and merger-related costs, was $1.05.

    Key highlights

    • Revenue (GAAP): $250.9 million, up 21.8% YoY
    • Operating income (GAAP): $8.0 million, against a loss of $12.3 million a year earlier
    • Net income (GAAP): $8.9 million, against a loss of $9.9 million a year earlier
    • Diluted EPS (GAAP): $0.26, against a loss of $0.30 a year earlier
    • Adjusted diluted EPS (company-defined, non-GAAP): $1.05

    Summary

    Consolidated (GAAP) $ million
    ParticularsQ3 2026Q3 2025YoY
    Revenue250.9206.0+21.8%
    8.0-12.3n/a
    8.9-9.9n/a
    Diluted EPS ($)0.26-0.30n/a

    Figures are in $ million except EPS; YoY compares with Q3 2025. Q3 2026 is the three months to 3 Oct 2026, from the company's release. Earlier quarters are the release's own comparatives, not cross-checked against SEC XBRL data. GAAP; net income attributable to the company; diluted EPS. Changes and margins computed by Blacklitt.

    The table shows GAAP revenue up 21.8% from a year earlier, to $250.9 million from $206.0 million. GAAP operating income was $8.0 million, against a loss of $12.3 million a year earlier, and the operating margin was 3.2% of revenue against -6.0%, which is 9.2 percentage points higher.

    GAAP net income was 3.5% of revenue, against -4.8% a year earlier, 8.3 percentage points higher. The year-ago figures are the comparatives printed in the release. The CEO said revenue rose 10% sequentially in the quarter.

    Adjusted figures exclude stock compensation and merger costs

    The company's adjusted figures are non-GAAP measures it defines itself. They leave out stock-based pay, the amortization of purchased intangibles and merger costs, plus other items named in the release's reconciliation tables.

    Adjusted diluted EPS was $1.05 against GAAP diluted EPS of $0.26. Non-GAAP gross margin was 61.0% against a GAAP gross margin of 60.8%. Non-GAAP operating income was $40 million, a 16.0% margin, against GAAP operating income of $8.0 million.

    Medical and segment revenue rose

    Industrial & Commercial revenue was $141 million, up 20% year-over-year, and Home & Life revenue was $110 million, up 24%.

    The company said medical revenue reached a new quarterly record, up 48% sequentially and more than 300% year-over-year. The company added that distributors held less stock, at a multi-year low, and that end customers' inventories were close to record lows in the quarter.

    Guidance suspended pending the Texas Instruments deal

    Silicon Labs has suspended forward-looking guidance. The company said the suspension is linked to its announced pending acquisition by Texas Instruments.

    For the nine months ended 3 Oct 2026, net cash provided by operating activities was $37.2 million, and purchases of property and equipment were $28.5 million. Cash and cash equivalents were $423.0 million at 3 Oct 2026.

    The CEO said current backlog and design-win ramps position the company for continued revenue growth and meaningful earnings expansion.

    Inference

    Diluted weighted-average shares were 33,752 thousand in the quarter, against 32,835 thousand a year earlier, and the EPS figures above are on that count. The release does not state any share repurchase or dividend for the quarter.

    The release does not give a dollar amount for medical revenue or a closing date for the Texas Instruments acquisition.

    Filed with the US SEC on . Reference: Original filing (SEC)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

    Latest posts